Your browser doesn't support javascript.
loading
Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation.
Xu, Ziheng; Choi, Jaebok; Cooper, Matthew; King, Jeffrey; Fiala, Mark A; Liu, Jingxia; Pusic, Iskra; Romee, Rizwan; Cashen, Amanda; Jacoby, Meagan A; Stockerl-Goldstein, Keith; Abboud, Camille; Vij, Ravi; Uy, Geoffrey; Westervelt, Peter; Walter, Matthew J; DiPersio, John F; Schroeder, Mark A.
Affiliation
  • Xu Z; Washington University School of Medicine, St. Louis, Missouri.
  • Choi J; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Cooper M; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • King J; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Fiala MA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Liu J; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
  • Pusic I; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Romee R; Department of Medicine, Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cashen A; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Jacoby MA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Stockerl-Goldstein K; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Abboud C; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Vij R; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Uy G; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Westervelt P; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Walter MJ; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • DiPersio JF; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Schroeder MA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri. Electronic address: markschroeder@wustl.edu.
Transplant Cell Ther ; 29(11): 699.e1-699.e9, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37597685
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Limits: Humans Language: En Journal: Transplant Cell Ther Year: 2023 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Limits: Humans Language: En Journal: Transplant Cell Ther Year: 2023 Document type: Article Country of publication: United States